Neurofibroma pathophysiology

Revision as of 14:20, 12 November 2015 by Shanshan Cen (talk | contribs)
Jump to navigation Jump to search

Neurofibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neurofibroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurofibroma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurofibroma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurofibroma pathophysiology

CDC on Neurofibroma pathophysiology

Neurofibroma pathophysiology in the news

Blogs on Neurofibroma pathophysiology

Directions to Hospitals Treating Neurofibroma

Risk calculators and risk factors for Neurofibroma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Pathophysiology

Neurofibromas infiltrate the nerve and splay apart the individual nerve fibers. Although usually benign, Neurofibromas can sometimes degenerate into cancer.

Single neurofibromas often occur in middle and old age and grow at the margins of the peripheral nerves, displacing the nerve's main body.

The vestibulocochlear (acoustic) nerve is the most commonly affected, (see acoustic neuroma). Other cranial nerves and spinal nerves are less commonly involved.

References


Template:WikiDoc Sources